Cargando…

A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection

PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B vira...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Myron John, Hsu, Leeyen, Hsien, Carlos, Kao, Jia-Horng, Durazo, Francisco Antonio, Saab, Sammy, Blatt, Lawrence Mitchell
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896649/
https://www.ncbi.nlm.nih.gov/pubmed/20827410
http://dx.doi.org/10.1007/s12072-010-9179-1
_version_ 1782183375323267072
author Tong, Myron John
Hsu, Leeyen
Hsien, Carlos
Kao, Jia-Horng
Durazo, Francisco Antonio
Saab, Sammy
Blatt, Lawrence Mitchell
author_facet Tong, Myron John
Hsu, Leeyen
Hsien, Carlos
Kao, Jia-Horng
Durazo, Francisco Antonio
Saab, Sammy
Blatt, Lawrence Mitchell
author_sort Tong, Myron John
collection PubMed
description PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B viral markers in 317 patients who were enrolled in a prospective study and identified the frequency of these tests in immune-tolerant (IT) patients, in inactive carriers, and in patients with either hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis or cirrhosis. RESULTS: IT patients were youngest (median age 27 years) and HBeAg-negative patients with cirrhosis were oldest (median age 58 years) (p = 0.03 to <0.0001). The male to female ratio was similar both in IT patients and in inactive carriers, but there was a male preponderance both in patients with chronic hepatitis and in patients with cirrhosis (p < 0.0001). The A1896 precore mutants were most prevalent in inactive carriers (36.4%) and HBeAg-negative patients with chronic hepatitis (38.8%; p < 0.0001), and the T1762/A1764 basal core promoter mutants were most often detected in HBeAg-negative patients with cirrhosis (65.1%; p = 0.02). Genotype A was detected only in 5.3% of IT patients, and genotype B was least often detected in both HBeAg-Positive patients with chronic hepatitis and cirrhosis (p = 0.03). The hepatitis B viral DNA levels were lowest in inactive carriers (2.69 log(10) IU/mL) and highest in IT patients (6.80 log(10) IU/mL; p = 0.02 to <0.0001). At follow-up, HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for 57 of 64 (89.1%) liver-related deaths (p < 0.0001). CONCLUSION: Differences in baseline hepatitis B viral markers were detected in patients in various clinical stages of hepatitis B virus infection. HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for the majority of the liver-related fatalities.
format Text
id pubmed-2896649
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28966492010-07-29 A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection Tong, Myron John Hsu, Leeyen Hsien, Carlos Kao, Jia-Horng Durazo, Francisco Antonio Saab, Sammy Blatt, Lawrence Mitchell Hepatol Int Original Article PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B viral markers in 317 patients who were enrolled in a prospective study and identified the frequency of these tests in immune-tolerant (IT) patients, in inactive carriers, and in patients with either hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis or cirrhosis. RESULTS: IT patients were youngest (median age 27 years) and HBeAg-negative patients with cirrhosis were oldest (median age 58 years) (p = 0.03 to <0.0001). The male to female ratio was similar both in IT patients and in inactive carriers, but there was a male preponderance both in patients with chronic hepatitis and in patients with cirrhosis (p < 0.0001). The A1896 precore mutants were most prevalent in inactive carriers (36.4%) and HBeAg-negative patients with chronic hepatitis (38.8%; p < 0.0001), and the T1762/A1764 basal core promoter mutants were most often detected in HBeAg-negative patients with cirrhosis (65.1%; p = 0.02). Genotype A was detected only in 5.3% of IT patients, and genotype B was least often detected in both HBeAg-Positive patients with chronic hepatitis and cirrhosis (p = 0.03). The hepatitis B viral DNA levels were lowest in inactive carriers (2.69 log(10) IU/mL) and highest in IT patients (6.80 log(10) IU/mL; p = 0.02 to <0.0001). At follow-up, HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for 57 of 64 (89.1%) liver-related deaths (p < 0.0001). CONCLUSION: Differences in baseline hepatitis B viral markers were detected in patients in various clinical stages of hepatitis B virus infection. HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for the majority of the liver-related fatalities. Springer-Verlag 2010-04-07 /pmc/articles/PMC2896649/ /pubmed/20827410 http://dx.doi.org/10.1007/s12072-010-9179-1 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Tong, Myron John
Hsu, Leeyen
Hsien, Carlos
Kao, Jia-Horng
Durazo, Francisco Antonio
Saab, Sammy
Blatt, Lawrence Mitchell
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
title A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
title_full A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
title_fullStr A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
title_full_unstemmed A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
title_short A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
title_sort comparison of hepatitis b viral markers of patients in different clinical stages of chronic infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896649/
https://www.ncbi.nlm.nih.gov/pubmed/20827410
http://dx.doi.org/10.1007/s12072-010-9179-1
work_keys_str_mv AT tongmyronjohn acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT hsuleeyen acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT hsiencarlos acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT kaojiahorng acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT durazofranciscoantonio acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT saabsammy acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT blattlawrencemitchell acomparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT tongmyronjohn comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT hsuleeyen comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT hsiencarlos comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT kaojiahorng comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT durazofranciscoantonio comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT saabsammy comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection
AT blattlawrencemitchell comparisonofhepatitisbviralmarkersofpatientsindifferentclinicalstagesofchronicinfection